PR Newswire
PTC Therapeutics to Participate at Upcoming Investor Conferences
📊
AI Sentiment
Positive
6/10
- Home
- PTC
PTC
PTC Inc.
as of 02-26-2026 9:36am EST
$155.39
+$1.27
+0.83%
PTC is a US-based global company that offers high-end computer-assisted design, product lifecycle management, and augmented reality solutions that industrial manufacturers commonly use on factory floors. Founded in 1985, PTC is a major player in parametric design and serves some of the world's most well-known equipment manufacturers, such as Caterpillar, Garmin, and Thermo Fisher.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 18.6B | IPO Year: | 1995 |
| Target Price: | $195.18 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.39 | EPS Growth: | 94.87 |
| 52 Week Low/High: | $133.38 - $219.69 | Next Earning Date: | 05-07-2026 |
| Revenue: | $2,739,226,000 | Revenue Growth: | 19.18% |
| Revenue Growth (this year): | 4.12% | Revenue Growth (next year): | 6.87% |
| P/E Ratio: | 110.87 | Index: | |
| Free Cash Flow: | 856.7M | FCF Growth: | +12.68% |
Stock Insider Trading Activity of PTC Inc. (PTC)
VON STAATS AARON C
Sell
EVP, Chief Legal Officer
PTC Feb 11, 2026
Avg Cost/Share
$161.65
Shares
240
Total Value
$38,664.27
Owned After
22,229
Talvitie Kristian
Sell
EVP, Chief Financial Officer
PTC Dec 9, 2025
Avg Cost/Share
$173.32
Shares
50,291
Total Value
$8,707,634.35
Owned After
22,616
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| VON STAATS AARON C | PTC | EVP, Chief Legal Officer | Feb 11, 2026 | Sell | $161.65 | 240 | $38,664.27 | 22,229 | |
| Talvitie Kristian | PTC | EVP, Chief Financial Officer | Dec 9, 2025 | Sell | $173.32 | 50,291 | $8,707,634.35 | 22,616 |
Latest PTC Inc. News
PTC Breaking Stock News: Dive into PTC Ticker-Specific Updates for Smart Investing
Simply Wall St.
How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations
📊
AI Sentiment
Positive
6/10
Motley Fool
ServiceTitan Down 39%, but This $8 Million Buy Lifted One Fund's Stake to a 16% Portfolio Bet
📊
AI Sentiment
Positive
7/10
Motley Fool
Belden Stock Up 27% as $11 Million New Stake Signals Confidence in $2.7 Billion Revenue Run
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
AI Bust or a Once-in-a-Decade Buying Opportunity for This Software Stock?
📊
AI Sentiment
Positive
6/10
Investing.com
PTC Therapeutics stock down over 2% on worse-than-expected Q4 results, guidance
âž–
AI Sentiment
Neutral
4/10
Insider Monkey
PTC Inc. (PTC) Faces Price Target Cuts, But Analysts See Stability
📊
AI Sentiment
Positive
6/10
Compare PTC vs Leading Stocks
See how PTC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PTC PTC Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.